Advertisement

Topics

FDA OKs Sapien 3 for Mitral, Aortic Valve-in-Valve Replacement

13:14 EDT 5 Jun 2017 | Medscape

Limited to high-surgical-risk patients, the expanded indication marks the first approval of any transcatheter valve for treatment of failed mitral and aortic bioprostheses, says the agency.
FDA Approvals

Original Article: FDA OKs Sapien 3 for Mitral, Aortic Valve-in-Valve Replacement

NEXT ARTICLE

More From BioPortfolio on "FDA OKs Sapien 3 for Mitral, Aortic Valve-in-Valve Replacement"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...